Noncanonical NF-κB Signaling Upregulation in Inflammatory Bowel Disease Patients is Associated With Loss of Response to Anti-TNF Agents

Objectives: Targeting tumor necrosis factor (TNF) with biologic agents, such as infliximab and adalimumab, is a widely used and effective therapeutic strategy in inflammatory bowel disease (IBD). Unfortunately, a significant number of patients fail to respond or lose response over time to these agen...

Full description

Saved in:
Bibliographic Details
Main Authors: Vu Q. Nguyen (Author), Kristin Eden (Author), Holly A. Morrison (Author), Megan B. Sammons (Author), Kristin K. Knight (Author), Siena Sorrentino (Author), Rebecca M. Brock (Author), Douglas J. Grider (Author), Irving C. Allen (Author), Dario Sorrentino (Author)
Format: Book
Published: Frontiers Media S.A., 2021-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available